Dr. Stefan Oschmann is a successful business executive, a visionary from the research-based economy and a proven expert in medicine and biotechnology.
He served as Chairman of the Management Board and CEO of Merck KGaA where he successfully led the transformation of the company into a leading science and technology company. During his tenure Merck developed and launched two blockbuster products in neuroscience and oncology.
He was chairman of the world pharma association IFPMA and of the European pharma association EFPIA. After his retirement from Merck Stefan served as chairman of UCB and AiCuris and works as a partner at private equity firm Armira. Prior to Merck, Stefan served in senior roles such as President Emerging Markets and President Europe/Middle East/Africa at the US corporation Merck & Co. (MSD).
Stefan had started at MSD in R&D and prior to that worked in a research function at the International Atomic Energy Agency. Stefan holds a doctorate (DVM) from the University of Munich.
